COL17A1 and cancer: This study demonstrated that upregulation of NEIL1 enhances colorectal cancer initiation through the formation of an RNA polymerase II transcriptional complex with SATB2 and cMyc, which drives COL17A1 expression leading to cancer-associated immunosuppression.